NEW YORK (GenomeWeb News) – Medical Solutions will be the exclusive UK distributor and service provider for Empire Genomics’ AccuArray array comparative genomic hybridization genotyping technology under an alliance announced today.
In addition to distributing the technology, Nottingham, UK-based Medical Solutions said that it would offer genotyping services, including in-house bioinformatics analysis and support, using the technology in its labs. The AccuArray also has applications in clinical diagnostics and pharmacogenetic testing, the firms said.
“The diagnostic capability of this assay is of particular interest to those groups in the healthcare community involved in cytogenetic and pre- and post-natal testing,” Tom Weaver, commercial director for Medical Solutions, said in a statement.
He said the AccuArray aCGH could be used to identify genetic aberrations linked with several diseases and conditions, such as cancer, autism, Alzheimer’s, several congenital abnormalities, and Down Syndrome.
Terms of the alliance were not disclosed.